•  
  •  
 

Turkish Journal of Medical Sciences

Abstract

Background/aim: To evaluate the clinical, demographic, and complication data of patients with new-onset uveitis at the ophthalmology and rheumatology departments of a single center.

Materials and methods: This retrospective study included patients newly diagnosed with uveitis who were referred to the rheumatology department for etiological evaluation between August 2021 and August 2024. Patients with a history of rheumatologic diseases associated with uveitis were not included in the study.

Results: A total of 91 patients (female: n = 59, 65%) who met the inclusion criteria were enrolled in the study. The mean age at uveitis diagnosis was 45.7 ± 14.8 years. The most common form of uveitis was anterior uveitis (81.3%), followed by intermediate uveitis (14.3%) and panuveitis (4.4%). About one-third of the patients had a rheumatologic etiology (n = 29, 31.9%), with spondyloarthritis being the most common. Approximately one in five patients with newly diagnosed uveitis of rheumatologic etiology developed ocular complications (n = 5, 17.2%), 80% (n = 4) of whom had anterior uveitis and 20% (n = 1) of whom had panuveitis. Macular edema was the most common ocular complication.

Conclusion: Anterior uveitis is generally regarded as more benign, but it still carries a risk of complications. Timely identification and management of systemic autoimmune diseases associated with uveitis may provide a valuable opportunity to prevent ocular complications and visual impairment.

Author ORCID Identifier

HANDAN YARKAN TUĞSAL: 0000-0003-0633-790X

SERDAR SEZER: 0000-0001-5401-5599

GÖZDE ORMAN: 0000-0001-5223-3816

GÜLTEN SUNGUR: 0000-0002-4440-0941

DOI

10.55730/1300-0144.6076

Keywords

complication, rheumatology, uveitis

First Page

1220

Last Page

1234

Publisher

The Scientific and Technological Research Council of Türkiye (TÜBİTAK)

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Share

COinS